PURPOSE: Because of its paramagnetic properties, oxygen may act as an endogenous magnetic resonance imaging contrast agent by changing proton relaxation rates. Changes in tissue oxygen concentrations have been shown to produce changes in relaxation rate R1 of water. The aim of the study was to improve the sensitivity of oxygen enhanced R1 imaging by exploiting the higher solubility of oxygen in lipids (as compared with water) to sensitively monitor changes in tissue oxygen levels by selectively measuring the R1 of lipids. METHODS: The method, with the acronym "MOBILE" (mapping of oxygen by imaging lipids relaxation enhancement), was applied in different mouse models of hypoxic processes on a 11.7 T magnetic resonance imaging system. MOBILE was compared with R*2, R1 of water, and with pO2 measurements (using electron paramagnetic resonance oximetry). MOBILE was also applied in the brain of healthy human volunteers exposed to an oxygen breathing challenge on a 3 T magnetic resonance imaging system. RESULTS: MOBILE was shown to be able to monitor changes in oxygenation in tumor, peripheral, liver, and brain tissues. The clinical translation was demonstrated in human volunteers. CONCLUSION: MOBILE arises as a promising noninvasive and sensitive tool for diagnosis and therapeutic guidance in disorders involving hypoxia.
PURPOSE: Because of its paramagnetic properties, oxygen may act as an endogenous magnetic resonance imaging contrast agent by changing proton relaxation rates. Changes in tissue oxygen concentrations have been shown to produce changes in relaxation rate R1 of water. The aim of the study was to improve the sensitivity of oxygen enhanced R1 imaging by exploiting the higher solubility of oxygen in lipids (as compared with water) to sensitively monitor changes in tissue oxygen levels by selectively measuring the R1 of lipids. METHODS: The method, with the acronym "MOBILE" (mapping of oxygen by imaging lipids relaxation enhancement), was applied in different mouse models of hypoxic processes on a 11.7 T magnetic resonance imaging system. MOBILE was compared with R*2, R1 of water, and with pO2 measurements (using electron paramagnetic resonance oximetry). MOBILE was also applied in the brain of healthy human volunteers exposed to an oxygen breathing challenge on a 3 T magnetic resonance imaging system. RESULTS: MOBILE was shown to be able to monitor changes in oxygenation in tumor, peripheral, liver, and brain tissues. The clinical translation was demonstrated in human volunteers. CONCLUSION: MOBILE arises as a promising noninvasive and sensitive tool for diagnosis and therapeutic guidance in disorders involving hypoxia.
Authors: Yunzhou Shi; Jason Oeh; Jeffrey Eastham-Anderson; Sharon Yee; David Finkle; Franklin V Peale; Jed Ross; Maj Hedehus; Nicholas van Bruggen; Rayna Venook; Sarajane Ross; Deepak Sampath; Richard A D Carano Journal: Neoplasia Date: 2013-11 Impact factor: 5.715
Authors: Scott C Beeman; Ying-Bo Shui; Carlos J Perez-Torres; John A Engelbach; Joseph J H Ackerman; Joel R Garbow Journal: Magn Reson Med Date: 2015-07-14 Impact factor: 4.668
Authors: Heling Zhou; Rami R Hallac; Ramona Lopez; Rebecca Denney; Matthew T MacDonough; Li Li; Li Liu; Edward E Graves; Mary Lynn Trawick; Kevin G Pinney; Ralph P Mason Journal: Am J Nucl Med Mol Imaging Date: 2015-01-15
Authors: Dawen Zhao; Jesús Pacheco-Torres; Rami R Hallac; Derek White; Peter Peschke; Sebastian Cerdán; Ralph P Mason Journal: NMR Biomed Date: 2015-06-08 Impact factor: 4.044
Authors: James P B O'Connor; Jessica K R Boult; Yann Jamin; Muhammad Babur; Katherine G Finegan; Kaye J Williams; Ross A Little; Alan Jackson; Geoff J M Parker; Andrew R Reynolds; John C Waterton; Simon P Robinson Journal: Cancer Res Date: 2015-12-09 Impact factor: 12.701